EU drug regulator endorses Gilead's remdesivir as COVID-19 treatment - Reuters
5:41am PDT - June 25th, 2020 remdesivir - ReutersThe European healthcare regulator said on Thursday it had recommended conditionally approving Gilead Sciences Inc's antiviral treatment, remdesivir, for use in COVID-19 patients across the continent, just weeks after a speedy review.